Androstanolone benzoate

Androstanolone benzoate is a synthetic androgen and anabolic steroid (AAS) and a derivative of dihydrotestosterone (DHT). It is more specifically a C17β ester of androstanolone (dihydrotestosterone, DHT) with benzoic acid. Androstanolone benzoate is used in medicine in the treatment of androgen deficiency disorders.

Pharmacology[edit | edit source]

As an AAS, androstanolone benzoate is an agonist of the androgen receptor (AR), similarly to androgens like testosterone and DHT. It has strong androgenic effects and weak anabolic effects, as well as minimal estrogenic effects.

Chemistry[edit | edit source]

Androstanolone benzoate, also known as 5α-androstan-17β-ol-3-one 17β-benzoate, is a synthetic estrane steroid and a derivative of DHT. It is an ester of androstanolone with benzoic acid at the C17β position.

History[edit | edit source]

Androstanolone benzoate was first described in the scientific literature in 1961. It was developed for medical use by Roussel Uclaf in the 1960s.

Society and culture[edit | edit source]

Androstanolone benzoate is marketed under the brand name Astanolone. It is available only in a few countries, including France and Italy.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.